Graftys SA-医療機器分野:企業M&A・提携分析

◆英語タイトル:Graftys SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011692
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products find application in bone reconstructive and trauma surgery; fracture repair, complex fractures, tibial osteotomy and joint arthroplasty, among others. It works in partnership with research institutions in France for the development of its product pipeline. The company’s research platform focuses on the development of orthopedic, trauma, spine and dental devices for various indications. The company has a presence in France and the US. Graftys is headquartered in Aix-en-Provence, France.

Graftys SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Graftys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Graftys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Graftys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Graftys SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Graftys SA, Medical Equipment, Deal Details 10
Venture Financing 10
Graftys Secures US$5.3 Million In Third Venture Financing Round 10
Partnerships 11
Arthrex Enters Into Co-Development Agreement With Graftys 11
Smith & Nephew Orthopaedics Enters Into Distribution Agreement With Graftys 12
Graftys SA – Key Competitors 13
Graftys SA – Key Employees 14
Graftys SA – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Mar 31, 2016: GRAFTYS strengthens its management and operations 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Graftys SA, Medical Equipment, Key Facts 2
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Graftys SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Graftys SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Graftys SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Graftys SA, Deals By Market, 2011 to YTD 2017 8
Graftys SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Graftys Secures US$5.3 Million In Third Venture Financing Round 10
Arthrex Enters Into Co-Development Agreement With Graftys 11
Smith & Nephew Orthopaedics Enters Into Distribution Agreement With Graftys 12
Graftys SA, Key Competitors 13
Graftys SA, Key Employees 14

★海外企業調査レポート[Graftys SA-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kina Petroleum Ltd (KPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • eFFECTOR Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary eFFECTOR Therapeutics Inc (eFFECTOR) is a clinical-stage biopharmaceutical company that focuses on the discovery and development of selective translation regulators for the treatment of cancer. Its investigational compounds are designed to restore the translational control of processes that …
  • InsuLine Medical Ltd (INSL):医療機器:M&Aディール及び事業提携情報
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company offers products such as InsuPad and InsuPatch which are designed to improve the current meal-time insulin therap …
  • Jiangsu Jiuding New Material Co Ltd (002201):企業の財務・戦略的SWOT分析
    Jiangsu Jiuding New Material Co Ltd (002201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Oi S.A. (OIBR4):企業の財務・戦略的SWOT分析
    Oi S.A. (OIBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Lamar Advertising Company:企業の戦略・SWOT・財務分析
    Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report Summary Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • D. Western Therapeutics Institute Inc (4576):製薬・医療:M&Aディール及び事業提携情報
    Summary D. Western Therapeutics Institute Inc (DWTI) is a pharmaceutical product s developer. The company offers ophthalmic solution, WP-1303, H-1337, K-134 and DW-1002. It discovers and develops drugs for glaucoma. DWTI’s ophthalmic solution treats glaucoma and ocular hypertension treatment and art …
  • InterDigital, Inc. (IDCC):企業の財務・戦略的SWOT分析
    InterDigital, Inc. (IDCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • WEX Inc (WEX):企業の財務・戦略的SWOT分析
    WEX Inc (WEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • L’Oreal SA:戦略・SWOT・企業財務分析
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Oracle Financial Services Software Ltd (OFSS):企業の財務・戦略的SWOT分析
    Oracle Financial Services Software Ltd (OFSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • NovaMedica LLC-製薬・医療分野:企業M&A・提携分析
    Summary NovaMedica LLC is a drug company that offers gastroenterology and ophthalmology products. The company offers pharmaceutical and other medical products such as diagnostic equipment, medical devices and technologies designed to provide a solution for range of interrelated problems. It provides …
  • Integra LifeSciences Holdings Corporation:企業のM&A・事業提携・投資動向
    Integra LifeSciences Holdings Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Integra LifeSciences Holdings Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Techtronic Industries Co Ltd (669):企業の財務・戦略的SWOT分析
    Techtronic Industries Co Ltd (669) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Flowserve Corp (FLS):企業の財務・戦略的SWOT分析
    Flowserve Corp (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Northern Sun Mining Corp:企業の戦略・SWOT・財務分析
    Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BioClin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioClin Therapeutics Inc (BioClin) is a clinical stage biotechnology company developing protein therapeutics for genetic disorders. Its lead product candidate B-701 is a human monoclonal antibody which targets the activity of FGFR3 (fibroblast growth factor receptor 3) and does not interact …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆